title: Sildenafil for severe lymphatic malformations.
authors.forename: Glenda L
authors.initials: GL
authors.lastname: Swetman
authors.forename: David R
authors.initials: DR
authors.lastname: Berk
authors.forename: Shreyas S
authors.initials: SS
authors.lastname: Vasanawala
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Feinstein
authors.forename: Alfred T
authors.initials: AT
authors.lastname: Lane
authors.forename: Anna L
authors.initials: AL
authors.lastname: Bruckner
mesh_terms: D000284:Administration, Oral; D005260:Female; D006801:Humans; D007223:Infant; D044148:Lymphatic Abnormalities / Q000188:drug therapy*; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011687:Purines / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate